Hiv integrase inhibitors

Details for Australian Patent Application No. 2001269895 (hide)

Owner Bristol-Myers Squibb Company

Inventors Meanwell, Nicholas A.; Banville, Jaques; Johnson, Timothy D.; Walker, Michael A.

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2001269895

PCT Pub. Number WO01/96283

Priority 60/211,900 16.06.00 US

Filing date 18 June 2001

Wipo publication date 24 December 2001

Acceptance publication date 20 October 2005

International Classifications

C07C 235/00 Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms

Event Publications

20 October 2005 Application Accepted

  Published as AU-B-2001269895

16 February 2006 Standard Patent Sealed

8 February 2007 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001269896

2001269894-Methods and systems for providing medical data to a third party in accordance with configurable distribution parameters